Neural Stem Cells Derived From Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinsons Disease.
about
Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease.Initial graft size and not the innate immune response limit survival of engrafted neural stem cells.The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.Immunological Properties of Murine Parthenogenetic Stem Cell-Derived Cardiomyocytes and Engineered Heart MuscleCurrent progress in the derivation and therapeutic application of neural stem cells.Cell Therapy for Parkinson's Disease.
P2860
Neural Stem Cells Derived From Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinsons Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Neural Stem Cells Derived From ...... e Model of Parkinsons Disease.
@en
type
label
Neural Stem Cells Derived From ...... e Model of Parkinsons Disease.
@en
prefLabel
Neural Stem Cells Derived From ...... e Model of Parkinsons Disease.
@en
P2093
P2860
P356
P1433
P1476
Neural Stem Cells Derived From ...... e Model of Parkinsons Disease.
@en
P2093
Alexander Noskov
Andrew Crain
Andrey Semechkin
Caleb McEntire
D Eugene Redmond
Evan Y Snyder
Glenn Sherman
Ibon Garitaonandia
P2860
P304
P356
10.3727/096368916X691682
P577
2016-11-01T00:00:00Z